Lupus nephritis

Current update

Ramesh Saxena, Tina Mahajan, Chandra Mohan

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

Original languageEnglish (US)
Article number240
JournalArthritis Research and Therapy
Volume13
Issue number5
DOIs
StatePublished - Sep 28 2011

Fingerprint

Lupus Nephritis
Nephritis
Systemic Lupus Erythematosus
Morbidity
Kidney
Mortality
Therapeutics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Lupus nephritis : Current update. / Saxena, Ramesh; Mahajan, Tina; Mohan, Chandra.

In: Arthritis Research and Therapy, Vol. 13, No. 5, 240, 28.09.2011.

Research output: Contribution to journalArticle

Saxena, Ramesh ; Mahajan, Tina ; Mohan, Chandra. / Lupus nephritis : Current update. In: Arthritis Research and Therapy. 2011 ; Vol. 13, No. 5.
@article{14b39ffee457426aac40e828625fe7a0,
title = "Lupus nephritis: Current update",
abstract = "Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60{\%} of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.",
author = "Ramesh Saxena and Tina Mahajan and Chandra Mohan",
year = "2011",
month = "9",
day = "28",
doi = "10.1186/ar3378",
language = "English (US)",
volume = "13",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "5",

}

TY - JOUR

T1 - Lupus nephritis

T2 - Current update

AU - Saxena, Ramesh

AU - Mahajan, Tina

AU - Mohan, Chandra

PY - 2011/9/28

Y1 - 2011/9/28

N2 - Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

AB - Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

UR - http://www.scopus.com/inward/record.url?scp=81255196460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255196460&partnerID=8YFLogxK

U2 - 10.1186/ar3378

DO - 10.1186/ar3378

M3 - Article

VL - 13

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 5

M1 - 240

ER -